相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。THP-1 and Dictyostelium Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds
Adrian Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
Tanya Parish
EXPERT OPINION ON DRUG DISCOVERY (2020)
DMN-Tre Labeling for Detection and High-Content Screening of Compounds against Intracellular Mycobacteria
Henok A. Sahile et al.
ACS OMEGA (2020)
Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy
Yunlong Hu et al.
JOURNAL OF INFECTION (2020)
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
Chandrasekaran Padmapriyadarsini et al.
BMJ OPEN (2019)
NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G
Saqib Kidwai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Comprehensive Characterization of the Attenuated Double Auxotroph Mycobacterium tuberculosis ΔleuDΔpanCD as an Alternative to H37Rv
Jomien M. Mouton et al.
FRONTIERS IN MICROBIOLOGY (2019)
Comparison of human monocyte derived macrophages and THP1-like macrophages as in vitro models for M. tuberculosis infection
Abhilasha Madhvi et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2019)
Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages
Hyo-Won Han et al.
STEM CELL REPORTS (2019)
Harnessing the mTOR Pathway for Tuberculosis Treatment
Pooja Singh et al.
FRONTIERS IN MICROBIOLOGY (2018)
Identification of Novel Mycobacteria Inhibitors Against Mycobacterial Protein Kinase G
Yuichi Kanehiro et al.
FRONTIERS IN MICROBIOLOGY (2018)
The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling
Kimberly M. Sogi et al.
ACS INFECTIOUS DISEASES (2017)
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
Vera M. Kroesen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Host-Directed Therapeutic Strategies for Tuberculosis
Afsal Kolloli et al.
FRONTIERS IN MEDICINE (2017)
Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages
Flavia Sorrentino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis
Kaitlyn Schaaf et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
Yael Babichev et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis
Zakaria Hmama et al.
IMMUNOLOGICAL REVIEWS (2015)
Host-Directed Therapies for Tuberculosis
David M. Tobin
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
In Vivo Assessment of Drug Efficacy against Mycobacterium abscessus Using the Embryonic Zebrafish Test System
Audrey Bernut et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis
C. J. Cambier et al.
CELL (2014)
Mycobacterium tuberculosis Promotes Anti-apoptotic Activity of the Macrophage by PtpA Protein-dependent Dephosphorylation of Host GSK3α
Valerie Poirier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
Sarah A. Stanley et al.
PLOS PATHOGENS (2014)
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Kevin Pethe et al.
NATURE MEDICINE (2013)
Mycobacterium tuberculosis modulators of the macrophage's cellular events
Valerie Poirier et al.
MICROBES AND INFECTION (2012)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H+-ATPase to inhibit phagosome acidification
Dennis Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis
Dhiraj Kumar et al.
CELL (2010)
Identification of Host-Dependent Survival Factors for Intracellular Mycobacterium tuberculosis through an siRNA Screen
Shilpi Jayaswal et al.
PLOS PATHOGENS (2010)
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Zhenjian Cai et al.
MOLECULAR CELL (2009)
Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B
Horacio Bach et al.
CELL HOST & MICROBE (2008)
HTLV-1 Tax Oncoprotein Subverts the Cellular DNA Damage Response via Binding to DNA-dependent Protein Kinase
Sarah S. Durkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1
Coenraad Kuijl et al.
NATURE (2007)
The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block
Tathagata Choudhuri et al.
JOURNAL OF VIROLOGY (2007)
Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs
SL Sampson et al.
INFECTION AND IMMUNITY (2004)
Genomic profiling of iron-responsive genes in Salmonella enterica serovar typhimurium by high-throughput screening of a random promoter library
J Bjarnason et al.
JOURNAL OF BACTERIOLOGY (2003)
Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis:: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy
L Amaral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
分享论文
